Sabinsa Corporation has successfully concluded its patent infringement lawsuit against Aegle Bios, Inc. A final consent judgment was filed in the United States District Court in New Jersey on June 23, 2017. On June 8, 2016, Sabinsa filed suit against Aegle for willful infringement of the curcumin Patent No. 6,653,327, which protects Sabinsa's methods and formulations for tetrahydrocurcuminoids (THCs). The judgement stipulates that the patent was valid, enforceable, and properly issued by the US Patent and Trademark Office. Sabinsa has patents related to THCs in the United States, Europe, Australia, New Zealand, and other locations.
展开▼
